Trial Search Results

Virtue® Male Sling Fixation Study

This study is a multi-center study that will assess the efficacy and safety of suture fixation of the Virtue® Male Sling.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Coloplast A/S

Stanford Investigator(s):


  • Device: Coloplast Virtue® Male Sling


Inclusion Criteria:

   - Male subject at least 18 years of age with an estimated life expectancy of of more
   than 5 years

   - The subject has confirmed stress urinary incontinence (SUI) through medical history ,
   urodynamics, and/or physical exam for at least 6 months

   - The subject has completed post-void residual per protocol within 6 weeks prior to

   - The subject has completed cystoscopy as per protocol within 12 months prior to implant

   - The subject has intrinsic sphincter deficiency due to one of the following:
   post-transurethral resection of the prostate (TURP), simple open prostatectomy, or
   radical prostatectomy completed at least 6 months prior to implantation date

   - The subject has failed at least two non-invasive therapies, eg. pelvic/Kegel
   exercises, behavioral modification or biofeedback for at least 6 months

   - The subject is willing to have the Virtue® Male Sling implanted

   - The subject is able and willing to complete all follow-up visits and procedures
   indicated in the protocol

   - The subject has been informed of the nature of the study and agrees to its provisions
   and has provided written informed consent as approved by the local ethics committee of
   the respective site

Exclusion Criteria:

   - The subject is unable or unwilling to sign the informed consent form (ICF)and/or
   comply with all follow-up requirements according to the study protocol

   - The subject has an active urinary tract infection or active skin infection in region
   of surgery

   - The subject has serious bleeding disorders

   - The subject has incontinence due to neurogenic causes defined as multiple sclerosis,
   spinal cord/brain injury, cerebrovascular accident (CVA), detrusor-external sphincter
   dyssynergia, Parkinson's disease, or similar condition

   - The subject had a previous implant to treat stress urinary incontinence

   - The subject has undergone radiation, cryosurgery, or brachy therapy to treat prostate
   or other pelvic cancer within 6 months

   - The subject is likely to undergo radiation therapy within the next 6 months

   - The subject has active urethral or bladder neck stricture disease requiring continued

   - The subject has urge predominant incontinence

   - The subject has an atonic bladder or a postvoid residual (PVR) greater than or equal
   to 150 milliliters (mL)

   - The subject has a condition or disorder likely to require future transurethral

   - The subject is enrolled in a concurrent clinical study of any treatment (drug or
   device) that could affect continence function without sponsor's approval

   - The subject is deemed unfit for male sling implantation or participation in a research
   protocol as determined by attending physician

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting